###begin article-title 0
###xml 33 34 33 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 52 53 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 128 133 <span type="species:ncbi:9606">human</span>
Translesion replication of benzo[a]pyrene and benzo[c]phenanthrene diol epoxide adducts of deoxyadenosine and deoxyguanosine by human DNA polymerase iota
###end article-title 0
###begin p 1
###xml 95 117 95 117 <email xmlns:xlink="http://www.w3.org/1999/xlink">woodgate@helix.nih.gov</email>
To whom correspondence should be addressed. Tel: +1 301 496 6175; Fax: +1 301 594 1135; Email: woodgate@helix.nih.gov
###end p 1
###begin p 2
###xml 190 191 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 233 234 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 363 371 354 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 647 649 635 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;3</sup>
###xml 660 662 648 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;4</sup>
###xml 789 792 777 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1102 1109 1083 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 908 913 <span type="species:ncbi:9606">human</span>
Human DNA polymerase iota (poliota) is a Y-family polymerase whose cellular function is presently unknown. Here, we report on the ability of poliota to bypass various stereoisomers of benzo[a]pyrene (BaP) diol epoxide (DE) and benzo[c]phenanthrene (BcPh) DE adducts at deoxyadenosine (dA) or deoxyguanosine (dG) bases in four different template sequence contexts in vitro. We find that the BaP DE dG adducts pose a strong block to poliota-dependent replication and result in a high frequency of base misincorporations. In contrast, misincorporations opposite BaP DE and BcPh DE dA adducts generally occurred with a frequency ranging between 2 x 10-3 and 6 x 10-4. Although dTMP was inserted efficiently opposite all dA adducts, further extension was relatively poor, with one exception (a cis opened adduct derived from BcPh DE) where up to 58% extension past the lesion was observed. Interestingly, another human Y-family polymerase, polkappa, was able to extend dTMP inserted opposite a BaP DE dA adduct. We suggest that poliota might therefore participate in the error-free bypass of DE-adducted dA in vivo by predominantly incorporating dTMP opposite the damaged base. In many cases, elongation would, however, require the participation of another polymerase more specialized in extension, such as polkappa.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c1">1</xref>
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c2">2</xref>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 518 519 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 520 521 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 522 523 522 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 532 533 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 534 535 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 536 537 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f1">1</xref>
###xml 636 637 636 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 638 639 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 640 641 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 642 643 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c2">2</xref>
###xml 763 764 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c3">3</xref>
###xml 832 833 832 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 833 834 833 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 839 840 839 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 840 841 840 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 896 899 896 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 903 908 903 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 963 964 963 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c4">4</xref>
###xml 988 996 988 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1021 1022 1021 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 1082 1083 1082 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c5">5</xref>
###xml 1084 1085 1084 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c6">6</xref>
###xml 1119 1120 1119 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1197 1198 1197 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c7">7</xref>
###xml 1254 1255 1254 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c8">8</xref>
###xml 1256 1258 1256 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c15">15</xref>
###xml 1275 1276 1275 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c9">9</xref>
###xml 1277 1279 1277 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c11">11</xref>
###xml 1347 1349 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c16">16</xref>
###xml 1350 1352 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c18">18</xref>
Polycyclic aromatic hydrocarbons (PAHs) are common environmental contaminants which are metabolized in mammals by a pathway involving cytochrome P-450 and epoxide hydrolase to give mutagenic and carcinogenic bay-region diol epoxides (DEs) (1,2). Each DE exists as a pair of diastereomers, one in which the benzylic hydroxyl group and the epoxide oxygen are cis and one in which these groups are trans. The latter diastereomer, whose DNA adducts are the subject of this study, consists of a pair of enantiomers with (R,S,S,R) and (S,R,R,S) absolute configurations at the carbon atoms of the tetrahydro benzo ring (Fig. 1). Notably, the (R,S,S,R) enantiomer is both the predominant isomer formed on metabolism of the hydrocarbon as well as the most carcinogenic (2,3). The PAH DEs generally form covalent DNA adducts at the exocyclic N2 and N6 amino groups of guanine and adenine, respectively, by cis or trans opening of the epoxide ring at the benzylic position (4). On reaction with DNA in vitro, DEs derived from benzo[a]pyrene (BaP) are largely selective for G adduct formation (5,6), whereas DEs derived from benzo[c]phenanthrene (BcPh) form significant proportions (up to 88%) of dA adducts (7). Site-specific mutagenesis studies in both bacterial (8-15) and mammalian (9,11) cell systems, as well as random mutagenesis studies with the DEs (16-18), indicate that the DE and their DNA adducts can induce a variety of mutations at both dG and dA sites.
###end p 4
###begin p 5
###xml 51 67 51 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 183 185 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c19">19</xref>
###xml 186 188 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c21">21</xref>
###xml 425 427 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c22">22</xref>
###xml 428 430 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c24">24</xref>
###xml 780 782 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c22">22</xref>
###xml 783 785 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c24">24</xref>
###xml 786 788 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c26">26</xref>
###xml 985 987 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c27">27</xref>
###xml 988 990 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c28">28</xref>
###xml 1382 1384 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c29">29</xref>
###xml 1460 1476 1456 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 1601 1603 1588 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c29">29</xref>
###xml 1891 1897 1878 1884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 2068 2070 2055 2057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c30">30</xref>
###xml 2247 2255 2234 2242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 2260 2267 2247 2254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2339 2341 2326 2328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c30">30</xref>
###xml 2425 2433 2412 2420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 2459 2461 2446 2448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c31">31</xref>
###xml 2462 2464 2449 2451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c35">35</xref>
###xml 2501 2504 2486 2489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 2505 2508 2490 2493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">syn</italic>
###xml 2560 2562 2545 2547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c36">36</xref>
###xml 2563 2565 2548 2550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c37">37</xref>
###xml 2686 2688 2671 2673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c32">32</xref>
###xml 2837 2839 2818 2820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c31">31</xref>
###xml 2840 2842 2821 2823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c33">33</xref>
###xml 2843 2845 2824 2826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c35">35</xref>
###xml 51 67 <span type="species:ncbi:562">Escherichia coli</span>
###xml 608 620 <span type="species:ncbi:9606">participants</span>
###xml 1460 1476 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1547 1553 <span type="species:ncbi:9606">humans</span>
###xml 1891 1897 <span type="species:ncbi:562">E.coli</span>
###xml 2373 2378 <span type="species:ncbi:9606">human</span>
Replicative DNA polymerases (pols), exemplified by Escherichia coli polIII and poldelta from eukaryotes, are both highly accurate and processive when copying undamaged DNA templates (19-21). However, these enzymes are generally blocked by the presence of bulky or distortion-producing lesions in DNA, including PAH adducts, and either stall immediately before the lesion itself or after inserting a base opposite the lesion (22-24). The question then arises how such lesions can lead to heritable mutations rather than simply to blockage of replication. The answer lies in the discovery that many of the key participants in the mutagenic process are, in fact, DNA polymerases that can substitute for the replicative polymerase and facilitate lesion bypass (for recent reviews see 22,24-26 and references therein). Lesion bypass is also often referred to as translesion DNA synthesis (TLS) or translesion replication (TR) and is believed to occur in two mechanistically discrete steps (27,28). The first step is the incorporation of a base opposite the DNA adduct itself and this step can either be accurate or error-prone. The second step is extension from the (mis)incorporated base, so as to achieve complete lesion bypass. Many of the polymerases thought to be involved in translesion replication belong to the Y-family of DNA polymerases that are found in all kingdoms of life (29). Moreover, multiple Y-family orthologs are often present in one organism. Escherichia coli, for example, has two Y-family DNA polymerases, polIV and polV, while humans have four, poleta, poliota, polkappa and Rev1 (29). Studies in which the ability of Y-family polymerases to bypass BaP DE adducts have been investigated reveal that the accuracy and efficiency of lesion bypass of any given stereoisomer varies depending upon the enzyme utilized and the local sequence context of the lesion. For example, E.coli polV can bypass BaP DE dA adducts with moderate accuracy, while polIV only misinserts a base opposite the lesion and is unable to facilitate extension beyond the lesion (30). Similar differences in the ability of polIV and polV to bypass BaP DE dG adducts have also been observed. Whereas polIV bypasses BaP DE dG adducts efficiently and accurately in vitro and in vivo, polV copies these lesions rather inefficiently and with low fidelity (30). Variations in the ability of human Y-family polymerases to bypass BaP DE lesions in vitro have also been reported (31-35). Poleta, which normally bypasses a cis-syn thymine- thymine dimer efficiently and accurately (36,37), bypasses BaP DE dG adducts inefficiently and in the process usually misinserts dAMP or dGMP opposite the adducted dG (32). Polkappa, on the other hand, bypasses the BaP DE dG adducts with the greatest efficiency and predominantly incorporates dCMP opposite the lesion (31,33-35).
###end p 5
###begin p 6
###xml 28 36 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 160 162 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c38">38</xref>
###xml 163 165 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c40">40</xref>
###xml 878 880 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c38">38</xref>
###xml 974 975 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 978 979 957 958 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 1425 1431 <span type="species:ncbi:9606">humans</span>
Characterization of poliota in vitro reveals that its enzymatic properties can vary depending upon the local sequence context of template DNA or its structure (38-40). To determine how well poliota responds in general to PAHs, we have measured the ability of the enzyme to misincorporate opposite four stereoisomeric BaP DE dA adducts and two BcPh DE dA adducts in two different local sequence contexts as well as two BaP DE dG adducts in two different local sequence contexts. We have also measured its ability to extend the primer beyond the adducted base. In general, BaP DE dG adducts posed a strong block to poliota-dependent replication, and when bases were inserted opposite the lesion, misincorporations occurred with high frequency. In contrast, but in keeping with the ability of the enzyme to favor the correct incorporation of dTMP opposite unmodified dA templates (38), incorporation of dTMP opposite all six dA adducts was favored by factors of approximately103-104 over the incorporation of incorrect nucleotides. In most cases, poliota-dependent extension from the correctly paired, but structurally distorted, primer terminus was inefficient. However, we found that another Y-family DNA polymerase, polkappa, was able to extend dTMP that had been inserted opposite a BaP DE dA adduct by poliota. Based upon these observations, we suggest that poliota (probably in combination with polkappa) may help protect humans from the mutagenic consequences of exposure to PAHs by reducing the mutagenic potential of BaP DE dA and BcPh DE dA adducts.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
PAH-DNA adduct nomenclature
###end title 8
###begin p 9
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c32">32</xref>
###xml 544 545 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 714 717 714 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 721 726 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 886 887 886 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f1">1</xref>
###xml 964 969 964 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 970 974 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anti</italic>
###xml 994 999 994 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1000 1004 1000 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anti</italic>
###xml 1022 1025 1022 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1026 1030 1026 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anti</italic>
###xml 1048 1051 1048 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1052 1056 1052 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anti</italic>
###xml 1075 1078 1075 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1079 1083 1079 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anti</italic>
###xml 1102 1105 1102 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1106 1110 1106 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anti</italic>
###xml 1175 1176 1175 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1177 1178 1177 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 1417 1422 1417 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1424 1428 1424 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anti</italic>
In a number of previous studies, a system for naming purine-DE adducts has been utilized in which the configuration of the adducts is designated as (+) or (-), depending on the sign of the optical rotation of their parent DE. We find this system to be confusing, because it incorrectly implies known optical rotations for the adducts themselves and actually bears no direct relation to their structures. Consequently, in the present paper, as in previous studies (cf. 32), we use a convention that is based on the known absolute configuration (R or S) of the adducts at the point of attachment of the hydrocarbon to the exocyclic amino group of the purines, as well as the stereochemistry of epoxide ring opening (cis or trans) by this amino group. To facilitate comparisons with other work, we list here the dG and dA adducts used in this study (and whose structures are shown in Fig. 1), along with the alternative names in brackets as follows: BaP trans S [(+)-trans-anti]; BaP trans R [(-)-trans-anti]; BaP cis R [(+)-cis-anti]; BaP cis S [(-)-cis-anti]; BcPh cis S [(+)-cis-anti]; BcPh cis R [(-)-cis-anti]. Note, however, that there is no direct correspondence between R/S absolute configuration of the adducts and the signs used in the adduct names. As described in the Introduction, all the adducts in this study are derived from the same DE diastereomer, whose benzylic hydroxyl group and epoxide oxygen are trans (anti isomer), thus, for simplicity in the present study, we have not designated the diastereomer of the parent DE.
###end p 9
###begin title 10
Primers and templates for replication assays
###end title 10
###begin p 11
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c12">12</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c14">14</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c41">41</xref>
###xml 474 476 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c42">42</xref>
###xml 477 479 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c43">43</xref>
###xml 572 577 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 578 579 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 579 580 577 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 697 698 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 780 781 778 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 788 789 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 1136 1137 1134 1135 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1138 1139 1136 1137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1141 1142 1139 1140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1280 1281 1278 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1281 1282 1279 1280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 1439 1441 1431 1433 <sub xmlns:xlink="http://www.w3.org/1999/xlink">18</sub>
###xml 1617 1618 1608 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1618 1619 1609 1610 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 1873 1875 1860 1862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 2112 2124 2099 2111 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GAGTCTGCTCCC</underline>
###xml 2140 2152 2127 2139 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TTTAGAGTCTGC</underline>
###xml 2212 2224 2199 2211 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AATCCTTCCCCC</underline>
###xml 2240 2252 2227 2239 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TTCCCGAGCGGC</underline>
###xml 2403 2419 2390 2406 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TTTAGAGTCTGCAGTG</underline>
For most of our studies, the adducted templates contained a site-specific PAH lesion 4 bases from the end of a 16mer oligonucleotide template. The exception was a 29mer template in which a BaP DE trans S dA lesion was located 13 bases from the end of the template. Lesion-containing 16mer templates were prepared and purified as previously described (12-14,41). The 29mer template was synthesized on a 1.5 mumol scale by a semi-automated procedure essentially as described (42,43) except that a commercial 500 A dG controlled pore glass (44 mumol/g) support was used. The trans-N6-BaP DE-dA adducted phosphoramidite used in the manual coupling step consisted of a single diastereomer with known 10S configuration. Preparation and characterization of the diastereomerically pure 10R and 10S phosphoramidites will be described elsewhere. The 5'-dimethoxytrityl-protected oligonucleotide was subjected to HPLC at room temperature on a Higgins Analytical DNA Semi-Prep column (10 x 100 mm) (Thomson Instrument Co., Clear Brook, VA) eluted at 3 ml/min with a linear gradient that increased the percentage of solvent B in solvent A [0.1 M (NH4)2CO3 buffer, pH 7.0] from 20 to 100% over 15 min, where solvent B (re-adjusted to pH 7.0-7.4) is a 1:1 mixture of acetonitrile and solvent A (tr = 6.7 min). After standard cleavage of the dimethoxytrityl group, the deprotected oligonucleotide was purified by HPLC at 65degreesC on a Waters Xterra MS C18 column (2.5 mum, 4.6 x 50 mm) eluted at 1 ml/min with a linear gradient of solvent B in the above buffer that increased the composition of solvent B from 13 to 22% in 20 min (tr = 8.0 min). Templates without lesions and oligonucleotide primers complementary to the 3'-end of each template were synthesized using standard techniques and gel purified by Lofstrand Laboratories (Gaithersburg, MD). Primers were 5'-labeled with [gamma-32P]ATP (5000 Ci/mmol) (Amersham Pharmacia Biotech, Piscataway, NJ), using T4 polynucleotide kinase (Life Technologies, Gaithersburg, MD). For the 12mer primers/16mer templates, four different template sequence contexts were used: 5'-TTTA*GAGTCTGCTCCC-3' and 5'-CAGA*TTTAGAGTCTGC-3' were used for BaP DE and BcPh DE adducts of dA; 5'-TTCG*AATCCTTCCCCC-3' and 5'-GGGG*TTCCCGAGCGGC-3' were used for the two BaP DE adducts of dG. For the 16mer primer/29mer template, only one sequence context was used and this was 5'-GCTCGT CAGCAGA*TTTAGAGTCTGCAGTG-3'. In each case, the position of the adducted base is marked by an asterisk and the location of the primer is underlined.
###end p 11
###begin title 12
Enzymes
###end title 12
###begin p 13
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 247 249 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c38">38</xref>
###xml 370 376 355 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 476 478 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c44">44</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 266 271 <span type="species:ncbi:9606">human</span>
###xml 288 293 <span type="species:ncbi:9606">human</span>
###xml 370 376 <span type="species:ncbi:562">E.coli</span>
###xml 406 411 <span type="species:ncbi:9606">human</span>
###xml 481 484 <span type="species:ncbi:10116">Rat</span>
Wild-type glutathione S-transferase (GST)-tagged human poliota was purified from baculovirus-infected SF9 insect cells by glutathione-agarose (Pharmingen, San Diego, CA) chromatography and hydroxyapatite ion exchange chromatography, as described (38). A recombinant human polkappaDeltaC (human polkappa residues 1-560) with a His tag at its C-terminus was purified from E.coli essentially as described for human polkappaDeltaC purified from baculovirus-infected insect cells (44). Rat DNA polymerase beta was the generous gift of Dr S.H. Wilson (NIEHS, Research Triangle Park, NC).
###end p 13
###begin title 14
Replication reactions
###end title 14
###begin p 15
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 626 627 619 620 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1229 1230 1187 1188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1132 1135 <span type="species:ncbi:10116">rat</span>
Radiolabeled primer-template DNAs were prepared by annealing the 5'-32P-labeled primer to the unlabeled template DNA at a molar ratio of 1:1.5. The efficiency of annealing was examined by comparing the relative amounts of free primer and annealed primer-template that had been separated on a 12% native acrylamide gel. In all cases, we estimated that >95% of the radiolabeled primers were annealed to the corresponding template (data not shown). Standard 10 microl reactions contained 100 fmol annealed primer-template (expressed as primer termini), 30 fmol poliota (3 nM final concentration), 40 mM Tris-HCl pH 8.0, 5 mM MgCl2, 10 mM dithiothreitol (DTT), 250 microg/ml BSA, 60 mM KCl, 2.5% glycerol and 100 microM of each ultrapure dNTP (Amersham Pharmacia Biotech, NJ) and lasted for 30 min at 37degreesC. Where noted, KCl was omitted from the reactions and DTT was replaced with 10 mM beta-mercaptoethanol. In reactions containing the longer 29mer template, both the length of the reaction and the concentrations of polkappaDeltaC and poliota enzymes were varied as noted in the figure legends. Standard 10 microl reactions for rat polbeta contained 100 fmol primer-template, 25 fmol enzyme, 50 mM Tris-HCl pH 8.0, 10 mM MgCl2, 20 mM NaCl, 1 mM DTT, 0.2 mg/ml BSA, 2.5% glycerol and 100 microM of each ultrapure dNTP. After incubation at 37degreesC for 30 min, reactions were terminated by the addition of 10 microl of 95% formamide/10 mM EDTA and the reaction mixture was heated to 100degreesC for 5 min followed by immediate cooling at 0degreesC. Reaction mixtures (5 microl) were subjected to 20% polyacrylamide-7 M urea gel electrophoresis and replication products were visualized by autoradiography or Phosphor Imager analysis (Molecular Dynamics, CA, or Fujifilm Software Inc., CA).
###end p 15
###begin title 16
Kinetic analysis of replication products
###end title 16
###begin p 17
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c45">45</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c46">46</xref>
###xml 1119 1120 1108 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 1120 1123 1109 1112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 1128 1129 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 1129 1130 1118 1119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1423 1425 1412 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c38">38</xref>
###xml 1426 1428 1415 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c45">45</xref>
###xml 1429 1431 1418 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c46">46</xref>
Preliminary experiments were performed to identify DNA polymerase and dNTP concentrations and assay reaction times that would ensure 'single hit' conditions with no more than 20% of the radiolabeled primer utilized (45,46). As a consequence, the concentration of poliota used in the steady-state assays was reduced to 2.5 nM and the concentration of dNTPs was varied from 0.1 to 10 microM for the correct incoming dNTP and between 1 and 100 microM for incorrect nucleotides. Two minute reactions were performed for the incorporation of correct nucleotides, whereas those measuring incorporation of incorrect nucleotides varied from 10 to 30 min. All the reactions were initiated by addition of the appropriate dNTP. Reaction products were separated in a 20% polyacrylamide gel containing 7 M urea and gels were dried prior to quantitative analysis using ImageQuant (Molecular Dynamics, CA) and Image Gauge V3.4 (Fujifilm, Sunnyvale, CA) software. Saturation plots of velocity as a function of dNTP concentration were determined by dividing the percentage product generated by the respective reaction time. The apparent Vmax and Km values were derived from non-linear least squares fits to a rectangular hyperbola using the SigmaPlot software (SPSS, Chicago, IL). Nucleotide misincorporation frequencies were calculated as previously described, and the data presented are the averages of three or four separate experiments (38,45,46).
###end p 17
###begin title 18
RESULTS
###end title 18
###begin p 19
###xml 43 44 43 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c2">2</xref>
###xml 45 46 45 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c3">3</xref>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">supF</italic>
###xml 271 279 271 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 928 932 925 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">supF</italic>
###xml 973 977 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">supF</italic>
###xml 980 982 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c47">47</xref>
###xml 1205 1209 1202 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">supF</italic>
###xml 1230 1232 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c48">48</xref>
###xml 303 308 <span type="species:ncbi:9606">human</span>
BaP DE and BcPh DE are potent carcinogens (2,3) whose biological activity most likely results from the formation of covalent DNA adducts which are incorrectly replicated. Notably, the spectra of mutations generated in the supF gene in shuttle vectors treated with the DE in vitro and then replicated in human cells suggest that mutations at adducted dA or dG residues are not evenly distributed. Instead, mutations occur with high frequency at mutagenic 'hot-spots', whereas the same bases in other regions mutate much less frequently and are therefore considered mutagenic 'cold-spots'. Our present study was aimed at analyzing the ability of poliota to facilitate translesion replication of four stereoisomeric BaP DE and two BcPh DE adducts of adenosine that were incorporated into 16mer oligonucleotide templates in a sequence containing a hot-spot for BcPh DE-induced mutations (bases 137-122 of the template strand of the supF gene) and a cold-spot (bases 141-126 of supF) (47). Similarly, two BaP DE adducts of guanine were studied in sequences containing either a mutagenic hot-spot or cold-spot for BaP DE-induced mutations, corresponding to bases 161-176 and 102-117 of the coding strand of the supF gene, respectively (48).
###end p 19
###begin title 20
Poliota-dependent replication of two stereoisomeric BaP DE dG adducts in two template sequence contexts
###end title 20
###begin p 21
###xml 154 156 142 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 159 161 147 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;2</sup>
###xml 163 165 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c38">38</xref>
###xml 335 337 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c39">39</xref>
###xml 338 340 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c40">40</xref>
###xml 398 399 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f2">2</xref>
###xml 570 571 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f2">2</xref>
###xml 1213 1214 1195 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f2">2</xref>
###xml 1419 1420 1401 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf643tb1">1</xref>
###xml 1849 1850 1831 1832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf643tb1">1</xref>
###xml 2043 2045 2025 2027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c35">35</xref>
We have previously demonstrated that at undamaged template guanines the misincorporation frequency in one sequence context is in the range approximately10-1-10-2 (38). Our subsequent studies revealed that the frequency of poliota misincorporation and extension is, however, acutely sensitive to local sequence contexts and structures (39,40). Such sequence context variations can be seen in Figure 2, where misincorporation of dTMP or dAMP opposite the undamaged dG is clearly greater when the 5' template bases are G*CTT-5' compared to when they are G*GGG-5' (cf. Fig. 2, upper and lower panels, No lesion). In both sequence contexts, the BaP trans R and BaP trans S dG adducts posed strong blocks to poliota-dependent primer extension. Furthermore, the specificity of nucleotide misincorporation changed dramatically. Whereas the correct incorporation of dCMP is favored opposite the undamaged template G, in the G*CTT-5' sequence context dTMP incorporation appears to be favored over the other three nucleotides when the lesion is present. In contrast, in the G*GGG-5' sequence context, dAMP, dTMP or dCMP appear to be inserted with roughly equal efficiency. We have confirmed that the data reported in Figure 2, which were obtained under 'multiple hit' conditions, do in fact reflect a change in incorporation fidelity by performing kinetic analyses on the misincorporations in the G*CTT-5' sequence context (Table 1). Under these conditions, we see that dTMP incorporation opposite BaP trans S and BaP trans R dG adducts is favored by a factor of 6- to nearly 10-fold over the correct base pair, while misincorporations of dAMP occurred with a relative frequency of 0.22 or 0.51, respectively. We were unable to reliably detect incorporation of dGMP opposite either the BaP trans S or BaP trans R dG adducts under these assay conditions (Table 1). We note, however, that when the BaP trans S dG adduct is located in a different sequence context, dGMP misincorporation is apparently favored over the (mis)incorporation of all other dNTPs (35).
###end p 21
###begin title 22
Poliota-dependent replication of four stereoisomeric BaP DE dA adducts in two sequence contexts
###end title 22
###begin p 23
###xml 204 206 201 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;4</sup>
###xml 208 210 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c38">38</xref>
###xml 211 213 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c49">49</xref>
###xml 214 216 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c50">50</xref>
###xml 481 482 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f3">3</xref>
###xml 744 745 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f3">3</xref>
###xml 953 956 950 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 961 968 958 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans S</italic>
###xml 1047 1050 1044 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1055 1062 1052 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans R</italic>
###xml 1077 1078 1074 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f3">3</xref>
###xml 1173 1174 1170 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f3">3</xref>
Although poliota is generally considered a low fidelity enzyme when copying template G, T or C, it is actually relatively accurate when replicating template A, with misincorporations in the range 1-2 x 10-4 (38,49,50). This is recapitulated with the undamaged templates within the sequence context ATTT-5' or AGAC-5', where all of the primer is extended in the presence of dTMP and only faint incorporations are observed in the presence of the other nucleoside triphosphates (Fig. 3, No lesion). When copying templates containing BaP trans S, BaP trans R, BaP cis S and BaP cis R lesions in both sequence contexts, dTMP incorporation opposite the lesion is clearly favored, as in many of the reactions all of the primer had been utilized (Fig. 3). Interestingly, while misincorporation of dG and dA is clearly seen in the context of A*TTT-5', much lower levels are seen in the context of A*GAC-5'. Furthermore, within the A*TTT-5' sequence context, the cis and trans S BaP DE adducts appear to be less accurately replicated than the corresponding cis and trans R adducts (Fig. 3). In all cases the incorporation of dCMP opposite the lesion was virtually undetectable (Fig. 3). While dTMP appears to be efficiently incorporated opposite the lesion, little to no extension beyond any of the lesions was observed.
###end p 23
###begin p 24
###xml 233 234 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf643tb2">2</xref>
###xml 489 490 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 569 570 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 592 593 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf643tb2">2</xref>
###xml 613 614 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 614 617 611 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 618 619 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 619 620 616 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 652 653 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 792 794 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c38">38</xref>
###xml 878 879 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 884 885 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 948 949 933 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf643tb2">2</xref>
###xml 1104 1105 1077 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
To determine more accurately the fidelity of poliota-dependent misinsertion when copying the BaP trans S and BaP trans R dA adducts, we measured the frequency of misincorporation opposite both lesions in two sequence contexts (Table 2). Although incorporation of dTMP opposite all four lesions was observed under 'multiple hit' conditions, the Michaelis- Menten analysis of initial rates revealed that in both sequence contexts, the efficiency of correctly incorporating dTMP opposite the R configuration of the BaP DE dA adducts is almost 10 times higher than for the S configuration (Table 2). Furthermore, the Vmax/Km for incorporation opposite the R isomer in the A*TTT-5' context is only approximately4-fold lower than the efficiency of incorporating dTMP opposite undamaged template A (38). In contrast, the efficiencies of misincorporating dGMP or dAMP opposite both the R and S isomers were roughly similar in both sequence contexts (Table 2). As a consequence, the relative frequencies of misincorporating dGMP or dAMP opposite the BaP trans S dA adduct are approximately10-fold higher than the R isomer. Overall, the efficiency of incorporating bases (correct or incorrect) opposite both stereoisomers was slightly greater in the A*TTT-5' context compared to the A*GAC-5' context. Our data suggest, therefore, that for poliota-dependent replication of the BaP DE dA adducts, the efficiency and accuracy of nucleotide incorporation opposite the adducted base is largely dependent upon the stereoisomer of the lesion and that, to a lesser extent, the local sequence context contributes to the overall efficiency of the reaction.
###end p 24
###begin title 25
Poliota-dependent replication of two stereoisomeric BcPh DE dA adducts in two sequence contexts
###end title 25
###begin p 26
###xml 397 398 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f4">4</xref>
###xml 695 696 692 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f4">4</xref>
We have also investigated the ability of poliota to copy two stereoisomeric BcPh DE dA adducts in the same two sequence contexts. Overall, the pattern of misincorporation opposite BcPh DE dA adducts was similar to that observed with BaP DE dA. Based upon the amount of primer utilization, incorporation of dTMP opposite BcPh cis S and BcPh cis R is clearly favored in both sequence contexts (Fig. 4). However, although the correct base is inserted opposite the BcPh DE dA adduct, further elongation was essentially abolished. The striking exception was the BcPh cis S lesion when located in the A*-GAC-5' context, where significant extension was observed in the presence of all four dNTPs (Fig. 4).
###end p 26
###begin title 27
Comparison of poliota and polbeta when replicating BaP DE and BcPh DE dA lesions in two sequence contexts
###end title 27
###begin p 28
###xml 544 545 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c8">8</xref>
###xml 710 711 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f5">5</xref>
###xml 763 764 754 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f3">3</xref>
###xml 769 770 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f4">4</xref>
###xml 1012 1013 1000 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f5">5</xref>
###xml 1620 1621 1578 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f5">5</xref>
###xml 1902 1903 1845 1846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f5">5</xref>
Our primer extension assays suggest that for the four stereoisomers of BaP DE dA and the two stereoisomers of BcPh DE dA adducts studied, poliota can efficiently incorporate the correct base, dTMP, opposite the lesion, but in general is unable to elongate the correctly paired, yet presumably distorted, primer terminus. We were interested in determining how these properties might compare to another low fidelity DNA polymerase, polbeta. Previous studies have indicted that BaP DE adducts pose a strong block to polbeta-dependent replication (8). We therefore analyzed the ability of both enzymes to incorporate and bypass the four BaP DE and two BcPh DE adducts in the presence of all four nucleotides (Fig. 5). In agreement with the previous experiments (Figs 3 and 4), poliota efficiently incorporated a base opposite all six lesions in both sequence contexts, whereas further extension was generally limited. As noted above, the exception was the BcPh cis S dA adduct located in the A*-GAC-5' context (Fig. 5, lower panel, poliota, lane 8). We quantitated the extent of lesion bypass and found that under these conditions, approximately58% of the primers were elongated past the BcPh cis S adduct. In contrast, the second best bypass event was with the BaP trans S adduct in the A*TTT-5' context, which gave approximately9% lesion bypass. As noted above, whereas all of the primers were extended on the undamaged DNA template, the presence of the BaP DE or BcPh DE adducts largely blocked polbeta-dependent primer extension. Greatest incorporation was seen with the BaP trans S adduct in the A*TTT-5' context (Fig. 5, upper panel, polbeta, lane 4), where approximately5% of the primers were extended by 1 bp and synthesis terminated opposite the lesion. However, we do note that limited bypass (2-5% of primers) occurred with some of the BaP DE and BcPh DE adducts in both sequence contexts (Fig. 5).
###end p 28
###begin p 29
Our data demonstrate, therefore, the unique capacity of poliota to incorporate bases accurately and efficiently opposite BaP DE and BcPh DE dA adducts. In at least one sequence context, poliota can extend the primer beyond the adduct site so as to achieve unassisted lesion bypass.
###end p 29
###begin title 30
Ability of polkappa to extend bases inserted opposite BaP DE trans S dA by poliota
###end title 30
###begin p 31
###xml 655 679 639 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 754 766 735 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 798 810 773 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 1016 1028 984 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 1038 1040 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c51">51</xref>
###xml 1134 1135 1096 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f6">6</xref>
###xml 1379 1381 1333 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c34">34</xref>
###xml 1382 1384 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c44">44</xref>
###xml 1385 1387 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c52">52</xref>
###xml 1388 1390 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c53">53</xref>
###xml 1673 1674 1619 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f6">6</xref>
###xml 1984 1985 1918 1919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f6">6</xref>
###xml 2150 2151 2077 2078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f3">3</xref>
###xml 2162 2163 2089 2090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf643tb1">1</xref>
###xml 2535 2543 2420 2428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 568 573 <span type="species:ncbi:9606">human</span>
###xml 655 679 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 754 766 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 780 785 <span type="species:ncbi:9606">human</span>
###xml 798 810 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 958 963 <span type="species:ncbi:9606">human</span>
###xml 1016 1028 <span type="species:ncbi:4932">S.cerevisiae</span>
It is clear, however, that despite efficiently incorporating the correct base opposite both BaP DE dA and BcPh DE dA adducts, in a variety of sequence contexts, further poliota-dependent extension is generally limited. Given that the prevailing model for TR posits that it might occur in two steps, and could conceivably be facilitated by two different polymerases, we were interested in determining if the poliota-dependent incorporation might be extended by another polymerase. Candidate enzymes for such a reaction appear to be polzeta and polkappa. Unfortunately, human polzeta has yet to be purified and characterized at the biochemical level. While Saccharomyces cerevisiae polzeta is available, we chose not to investigate the combined actions of S.cerevisiae polzeta with human poliota, as S.cerevisiae does not possess a poliota ortholog and our assays would only serve as a cross-phyla hypothetical model. Instead, we chose to assay the ability of human polkappa, which has extension properties similar to S.cerevisiae polzeta (51), to extend poliota-dependent incorporations incurred opposite a BaP trans S dA adduct (Fig. 6). As controls for the reactions, we also assayed the ability of polkappa to extend an undamaged template as well as insert bases opposite the BaP trans S dA lesion. Consistent with earlier studies with both full-length and truncated polkappa (34,44,52,53), the polkappaDeltaC assayed in these studies extended the undamaged template efficiently, and the products were 1-2 bases shorter than one might expect based upon the length of the template, indicating that the enzyme stops synthesis 1 or 2 nt before the end of the template (Fig. 6). When replicating the BaP DE trans S lesion, polkappa appeared to favor the misincorporation of dAMP. However, the misincorporated dAMP was poorly extended, as was evident by the amount of primer extension in the presence of all four dNTPs (in the presence of various concentrations of polkappaDeltaC) (Fig. 6). In contrast to the weak misincoporation of dAMP opposite the BaP DE trans S lesion by polkappa, poliota efficiently incorporated the correct base, dTMP (cf. Fig. 3 and Table 1), but was largely unable to extend the correct base pair, even after prolonged reaction times. However, when polkappaDeltaC was added to reactions following poliota, the extent of lesion bypass increased considerably from approximately3-9% in the presence of polkappa, or poliota, respectively, to approximately30% in the presence of both enzymes. We conclude from these in vitro studies that while polkappa has some ability to insert an incorrect base opposite the BaP trans S dA adduct, it is unable to extend the mispair. It can nevertheless extend a base that is correctly incorporated opposite the adduct by another DNA polymerase, such as poliota.
###end p 31
###begin title 32
DISCUSSION
###end title 32
###begin p 33
###xml 205 208 205 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 209 212 209 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">syn</italic>
###xml 336 339 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 340 343 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">syn</italic>
###xml 459 461 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c36">36</xref>
###xml 462 464 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c37">37</xref>
###xml 465 467 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c54">54</xref>
###xml 564 566 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c31">31</xref>
###xml 567 569 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c44">44</xref>
###xml 570 572 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c52">52</xref>
###xml 664 666 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c31">31</xref>
###xml 667 669 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c33">33</xref>
###xml 670 672 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c35">35</xref>
###xml 782 784 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c32">32</xref>
###xml 273 278 <span type="species:ncbi:9606">human</span>
It is becoming increasingly clear that members of the Y-family of lesion bypass polymerases exhibit unique misincorporation and bypass properties. A good example is the relative accuracy and efficiency of cis-syn thymine-thymine dimer and BaP DE adduct bypass performed by human poleta, poliota and polkappa. Poleta is able to bypass a cis-syn cyclobutane thymine-thymine dimer accurately and efficiently while poliota does so inefficiently and inaccurately (36,37,54). Polkappa is unable to insert bases opposite the thymine-thymine cyclobutane pyrimidine dimer (31,44,52). In contrast, polkappa can bypass BaP DE adducted dG residues efficiently and accurately (31,33-35). Poleta bypasses the same lesion inefficiently and in doing so misinserts dAMP or dGMP opposite the lesion (32). We have shown here that BaP DE dG is also a significant block to poliota replication.
###end p 33
###begin p 34
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c55">55</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c56">56</xref>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c9">9</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c11">11</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c57">57</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c58">58</xref>
###xml 417 418 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf643tb1">1</xref>
###xml 535 542 526 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 555 563 546 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 640 642 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c32">32</xref>
###xml 643 645 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c35">35</xref>
###xml 684 686 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c59">59</xref>
###xml 701 703 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c31">31</xref>
###xml 704 706 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c33">33</xref>
###xml 707 709 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c35">35</xref>
###xml 727 734 709 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 901 903 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c60">60</xref>
###xml 990 997 964 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 748 753 <span type="species:ncbi:10090">mouse</span>
###xml 794 800 <span type="species:ncbi:10090">murine</span>
The spectra of mutations recovered from human cells (55) or mice (56) exposed to BaP or mammalian cells exposed to BaP DE (9,11,57,58) suggest that insertion of dAMP is favored at the adducted guanine. Under our assay conditions, we find that the BaP DE dG adducts pose strong blocks to poliota-dependent replication, and poliota predominantly inserts dTMP rather than dAMP when incorrect incorporations occur (Table 1). We conclude, therefore, that poliota is unlikely to play a major role in the bypass of dG adducted BaP DE lesions in vivo. Based upon in vitro data, that role appears to be performed in an error-prone manner by poleta (32,35) and an error-free manner by polzeta (59) or polkappa (31,33-35). Indeed, recent in vivo studies with mouse cells carrying a homozygous knockout of murine polkappa exhibited both an increased sensitivity to BaP and an increase in BaP-induced mutagenesis (60), suggesting that polkappa plays a major role in the error-free bypass of PAH adducts in vivo.
###end p 34
###begin p 35
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c38">38</xref>
###xml 384 386 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;3</sup>
###xml 389 391 374 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;4</sup>
###xml 506 508 491 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;2</sup>
###xml 516 517 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf643tb2">2</xref>
###xml 608 611 591 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 612 615 595 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">syn</italic>
###xml 640 642 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c37">37</xref>
###xml 683 685 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c33">33</xref>
###xml 686 688 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c34">34</xref>
###xml 958 965 934 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
In keeping with the ability of the enzyme to favor the correct incorporation of dTMP opposite unmodified dA templates (38), we find that poliota can accurately and efficiently insert dTMP opposite both BaP DE and BcPh DE dA adducts. Misincorporation frequencies were approximately10-fold higher at the BaP DE dA adducts compared to an undamaged base and were generally in the range 10-3-10-4. The exception was at the BaP trans S lesion where misincorporation of dAMP occurred with a frequency of 1.47 x 10-2 (Table 2). These misincorporation frequencies are in the same range as that observed for poleta at cis-syn thymine-thymine dimers (37) and for polkappa at BaP DE dG adducts (33,34), and both enzymes are considered as being error-free when copying these lesions. Thus, it is possible that one cellular role of poliota is to reduce the mutagenic potential of BaP DE and BcPh DE dA adducts through the correct incorporation of dTMP opposite the lesion in vivo.
###end p 35
###begin p 36
###xml 336 338 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c27">27</xref>
###xml 339 341 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c28">28</xref>
###xml 359 362 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 363 366 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">syn</italic>
###xml 434 436 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c36">36</xref>
###xml 437 439 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c37">37</xref>
###xml 620 622 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c54">54</xref>
###xml 745 757 731 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 879 881 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c49">49</xref>
###xml 882 884 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c61">61</xref>
###xml 1053 1065 1033 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 1185 1187 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c33">33</xref>
###xml 1188 1190 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c51">51</xref>
###xml 1256 1259 1225 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1260 1263 1229 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">syn</italic>
###xml 1287 1289 1256 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c31">31</xref>
###xml 1290 1292 1259 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c44">44</xref>
###xml 1293 1295 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c52">52</xref>
###xml 1423 1425 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c51">51</xref>
###xml 1617 1618 1582 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f6">6</xref>
###xml 1847 1848 1805 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf643f6">6</xref>
###xml 1961 1968 1912 1919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitr</italic>
###xml 2022 2027 1973 1978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 2030 2032 1981 1983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c62">62</xref>
###xml 2224 2232 2171 2179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 2260 2267 2207 2214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2277 2279 2224 2226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c60">60</xref>
###xml 745 757 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 781 786 <span type="species:ncbi:9606">human</span>
###xml 1053 1065 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 1075 1080 <span type="species:ncbi:9606">human</span>
###xml 1648 1653 <span type="species:ncbi:9606">human</span>
###xml 2104 2109 <span type="species:ncbi:9606">human</span>
Despite the efficient insertion of the correct base opposite the various PAH lesions, with the exception of the BcPh cis S lesion in one sequence context, further primer extension by poliota is largely inhibited. Current models of lesion bypass suggest that it may occur in a two-step process; (mis)incorporation followed by extension (27,28). In the case of cis-syn thymine-thymine dimers, poleta can perform both steps efficiently (36,37). We have previously hypothesized that efficient poliota-dependent bypass of a cyclobutane pyrimidine dimer might require the participation of another polymerase, such as polzeta (54). The possibility that poliota might work in such a two-step process has indeed been demonstrated in a model system where S.cerevisiae polzeta was mixed with human poliota so as to achieve bypass of a synthetic abasic site and a 6-4 thymine-thymine dimer (49,61). It does not seem unreasonable, therefore, that a similar two-step process might also occur at BaP DE and BcPh DE dA adducts. Recent studies have suggested that, like S.cerevisiae polzeta, human polkappa can elongate mispairs and certain (mis)incorporations inserted opposite certain damaged bases (33,51). For example, although polkappa cannot insert a base opposite a cis-syn thymine-thymine dimer (31,44,52), it can efficiently elongate dG and dA (but not dC or dT) bases that have been inserted opposite the 3'-thymine of the dimer (51). In a similar scenario, we found that polkappa has only a weak ability to incorporate a base opposite a BaP DE trans S dA adduct and, when it did, dAMP was the preferred incorporation (Fig. 6). In contrast, however, when human polkappa was added to replication reactions after poliota had apparently successfully incorporated dTMP opposite the lesion, significant extension and complete lesion bypass was observed (Fig. 6). Thus, the combined actions of both poliota and polkappa lead to complete bypass of a BaP DE trans S dA adduct in vitro. Our observations therefore parallel those of Zhang et al. (62), who found that polkappa was able to extend dCMP that was inserted by human Rev1 opposite BaP DE trans R or trans S dG lesions. Thus, based upon a considerable amount of data generated from in vitro studies, as well as recent in vivo studies (60), polkappa appears to play a major role in the bypass of PAHs. It can either bypass BaP DE adducted dG unassisted or it could play a role in TR by extending bases correctly inserted opposite BaP DE dG or dA adducts by Rev1 or poliota, respectively.
###end p 36
###begin p 37
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 120 127 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
While we hope that our in vitro studies with poliota begin to provide clues as to its possible role(s) in lesion bypass in vivo, its true biological function will probably only be determined with the characterization of mice or cell lines lacking poliota, and experiments toward generating such mice/cell lines are currently in progress.
###end p 37
###begin title 38
Figures and Tables
###end title 38
###begin p 39
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 162 163 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anti</italic>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
 Structures of BaP and BcPh and their diol epoxide (DE) metabolites, with derived DNA adducts (Base = dG or dA residue with the point of attachment at N2 of G or N6 of dA as indicated). Only adducts derived from the DE shown (two enantiomers of the diastereomer [DE-2 or 'anti' DE] in which the benzylic hydroxyl group and the epoxide oxygen are trans) were used in this study. The angular benzo ring of the hydrocarbon that is metabolized to the DE is shown in bold. Note that for cis adducts, the configuration at the benzylic C-10 or C-1 of the epoxide is retained, whereas for trans adducts it is inverted.
###end p 39
###begin p 40
###xml 96 97 93 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 102 103 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 294 295 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c4">4</xref>
 Ability of poliota to replicate two stereoisomeric BaP DE dG adducts in two sequence contexts (A and B). For each panel, the sequence of the primer-template used in the reaction is shown above the reactions. Reactions were performed for 30 min at 37degreesC in the presence of the four dNTPs (4) at 100 microM each or individually, G, A, T and C (at 100 microM). The template either contained no lesion or a G adduct indicated by an asterisk in the template.
###end p 40
###begin p 41
###xml 97 98 94 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 103 104 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 295 296 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c4">4</xref>
 Ability of poliota to replicate four stereoisomeric BaP DE dA adducts in two sequence contexts (A and B). For each panel, the sequence of the primer-template used in the reaction is shown above the reactions. Reactions were performed for 30 min at 37degreesC in the presence of the four dNTPs (4) at 100 microM each or individually, G, A, T and C (at 100 microM). The template either contained no lesion or an A adduct indicated by an asterisk in the template.
###end p 41
###begin p 42
###xml 97 98 94 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 103 104 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 295 296 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c4">4</xref>
 Ability of poliota to replicate two stereoisomeric BcPh DE dA adducts in two sequence contexts (A and B). For each panel, the sequence of the primer-template used in the reaction is shown above the reactions. Reactions were performed for 30 min at 37degreesC in the presence of the four dNTPs (4) at 100 microM each or individually, G, A, T and C (at 100 microM). The template either contained no lesion or a dA adduct indicated by an asterisk in the template.
###end p 42
###begin p 43
###xml 175 176 169 170 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 181 182 175 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 48 51 <span type="species:ncbi:10116">rat</span>
 Comparison of the ability of human poliota and rat polbeta to bypass four stereoisomeric BaP DE dA adducts or two stereoisomeric BcPh DE dA adducts in two sequence contexts (A and B). The sequence of the primer- template used in the reactions is shown above their respective panels. Reactions were performed for 30 min at 37degreesC in the presence of the four dNTPs at 100 microM each; in these assays, KCl was omitted from the reactions and DTT was replaced with 10 mM beta-mercaptoethanol. Lane 1, radiolabeled primer (no template); lane 2, no lesion; lane 3, BaP trans R; lane 4, BaP trans S; lane 5, BaP cis R; lane 6, BaP cis S; lane 7, BcPh cis R; lane 8, BcPh cis S.
###end p 43
###begin p 44
###xml 541 542 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf643c4">4</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
 Ability of human polkappa to misincorporate bases opposite a BaP DE trans S dA lesion and extend poliota-dependent incorporation of dTMP opposite BaP DE trans S dA. The sequence of the 16mer primer/29mer BaP DE dA template used in the reactions is shown above the replication assays. The location of the adduct is indicated by an asterisk. In these assays, KCl was omitted from the reactions and DTT was replaced with 10 mM beta-mercaptoethanol. Reactions were performed for the times noted at 37degreesC in the presence of the four dNTPs (4) at 100 microM each or individually, G, A, T and C (at 100 microM). The concentration of poliota was kept constant at 4 nM, while the concentration of polkappaDeltaC was varied as noted above each reaction. In the case of the poliota plus polkappa reactions, 4 nM poliota was allowed to extend the 16mer primer annealed to the damaged template in the presence of all four dNTPs (100 microM each) for 10 min before the subsequent addition of various concentrations of polkappaDeltaC for an additional 10 min. As a consequence, the total reaction time indicated on the figure for poliota is 20 min.
###end p 44
###begin title 45
Kinetic analysis of poliota-dependent incorporation opposite BaP trans R and BaP trans S dG adducts
###end title 45
###begin p 46
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 11 14 11 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 16 17 16 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 91 92 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 92 95 88 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 96 97 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 97 98 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 200 201 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 201 204 197 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 205 206 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 206 207 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
aUnits of Vmax/Km are the percentage primer extension product/min/micromol nucleotide. The Vmax/Km ratio was the average of three or more experiments with standard deviations not exceeding 20% of the Vmax/Km value.
###end p 46
###begin title 47
Kinetic analysis of poliota-dependent incorporation opposite BaP trans R and BaP trans S dA adducts in two DNA sequence contexts
###end title 47
###begin p 48
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 11 14 11 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 16 17 16 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 91 92 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 92 95 88 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 96 97 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 97 98 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 200 201 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 201 204 197 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 205 206 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 206 207 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
aUnits of Vmax/Km are the percentage primer extension product/min/micromol nucleotide. The Vmax/Km ratio was the average of three or more experiments with standard deviations not exceeding 20% of the Vmax/Km value.
###end p 48
###begin title 49
ACKNOWLEDGEMENTS
###end title 49
###begin p 50
###xml 258 261 <span type="species:ncbi:10116">rat</span>
We would like to thank members of the Section on DNA Replication, Repair and Mutagenesis and the Laboratory of Bioorganic Chemistry for their constructive comments during the course of this work. We also thank Sam Wilson (NIEHS) for kindly providing us with rat DNA polymerase beta. This work was supported by the NIH Intramural Research Program.
###end p 50
###begin title 51
REFERENCES
###end title 51

